Literature DB >> 21266558

Noninvasive analysis of portal pressure by contrast-enhanced sonography in patients with cirrhosis.

Chao-Xue Zhang1, Jing Hu, Kong-Wang Hu, Chao Zhang, Ling Wang, Jian-Ming Xu.   

Abstract

OBJECTIVES: Free portal pressure measurement is a reliable method for assessment of portal pressure in patients with cirrhosis. Intrahepatic circulatory time analysis of a sonographic contrast agent can assess liver fibrosis and its severity. The purposes of this pilot study were to assess the correlation between the intrahepatic circulatory time and free portal pressure and to assess whether intrahepatic circulatory time analysis can be used to predict portal venous pressure severity.
METHODS: The intrahepatic circulatory time and free portal pressure were measured in 31 patients with hepatitis B virus-related liver disease. Pearson correlation analysis was used to assess the correlation between the intrahepatic circulatory time and free portal pressure.
RESULTS: The hepatic vein-hepatic artery interval times were significantly shorter in the portal hypertension group than the non-portal hypertension group (mean ± SD, 8.26 ± 1.94 and 13.83 ± 1.17 seconds, respectively; P < .001). The portal vein-hepatic artery interval times were significantly longer in the portal hypertension group than the nonportal hypertension group (13.13 ± 2.25 and 7.25 ± 1.81 seconds; P < .001). Considering the whole patient population, there were statistically significant correlations between free portal pressure and the hepatic vein-hepatic artery interval time (r = -0.900; P < .001) and portal vein-hepatic artery interval time (r = 0.808; P < .001). In patients with portal hypertension, there was a statistically significant correlation between free portal pressure and the hepatic vein-hepatic artery interval time (r = -0.804; P = .009) and a weak correlation between free portal pressure and the portal vein-hepatic artery interval time (r = 0.506; P = .036).
CONCLUSIONS: Intrahepatic circulatory time measurement is correlated with free portal pressure and has the potential capability to evaluate portal pressure noninvasively in patients with hepatitis B virus-related liver disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21266558     DOI: 10.7863/jum.2011.30.2.205

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  9 in total

Review 1.  Portal pressure monitoring-state-of-the-art and future perspective.

Authors:  Gang Xu; Fei Li; Yilei Mao
Journal:  Ann Transl Med       Date:  2019-10

Review 2.  Non-invasive assessment of portal hypertension and liver fibrosis using contrast-enhanced ultrasonography.

Authors:  Hitoshi Maruyama; Gamal Shiha; Osamu Yokosuka; Ashish Kumar; Barjesh Chander Sharma; Alaa Ibrahim; Vivek Saraswat; Cosmas Rinaldi A Lesmana; Masao Omata
Journal:  Hepatol Int       Date:  2015-12-22       Impact factor: 6.047

3.  Simultaneous grayscale and subharmonic ultrasound imaging on a modified commercial scanner.

Authors:  J R Eisenbrey; J K Dave; V G Halldorsdottir; D A Merton; P Machado; J B Liu; C Miller; J M Gonzalez; S Park; S Dianis; C L Chalek; K E Thomenius; D B Brown; V Navarro; F Forsberg
Journal:  Ultrasonics       Date:  2011-05-10       Impact factor: 2.890

4.  Chronic liver disease: noninvasive subharmonic aided pressure estimation of hepatic venous pressure gradient.

Authors:  John R Eisenbrey; Jaydev K Dave; Valgerdur G Halldorsdottir; Daniel A Merton; Cynthia Miller; José M Gonzalez; Priscilla Machado; Suhyun Park; Scott Dianis; Carl L Chalek; Christopher E Kim; Jeffrey P Baliff; Kai E Thomenius; Daniel B Brown; Victor Navarro; Flemming Forsberg
Journal:  Radiology       Date:  2013-03-22       Impact factor: 11.105

5.  Severe portal hypertension in cirrhosis: evaluation of perfusion parameters with contrast-enhanced ultrasonography.

Authors:  Woo Kyoung Jeong; Tae Yeob Kim; Joo Hyun Sohn; Yongsoo Kim; Jinoo Kim
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

6.  Usefulness of Contrast-Enhanced Ultrasonography for Predicting Esophageal Varices in Patients with Hepatitis B Virus (HBV)-Related Cirrhosis.

Authors:  Jun Li; Jin-Chun Feng; Xin-Yu Peng; Xiang-Wei Wu; Ting-Ting Du; Jia-Jia Wang; Shu-Xin Tian; Gui-Lin Lu
Journal:  Med Sci Monit       Date:  2017-05-12

Review 7.  Ultrasonography for Noninvasive Assessment of Portal Hypertension.

Authors:  Hitoshi Maruyama; Osamu Yokosuka
Journal:  Gut Liver       Date:  2017-07-15       Impact factor: 4.519

8.  Diagnosing Portal Hypertension with Noninvasive Subharmonic Pressure Estimates from a US Contrast Agent.

Authors:  Ipshita Gupta; John R Eisenbrey; Priscilla Machado; Maria Stanczak; Corinne E Wessner; Colette M Shaw; Sriharsha Gummadi; Jonathan M Fenkel; Alison Tan; Cynthia Miller; Julia Parent; Susan Schultz; Michael C Soulen; Chandra M Sehgal; Kirk Wallace; Flemming Forsberg
Journal:  Radiology       Date:  2020-11-17       Impact factor: 11.105

9.  Antiviral therapy effectively improves liver hemodynamics as evidenced by serum biomarker and contrast-enhanced ultrasound examinations in patients with hepatitis B cirrhosis.

Authors:  Xiaoyong Xu; Chaoxue Zhang; Chen Shi; Naizhong Hu; Bin Sun; Derun Kong; Jianming Xu
Journal:  PeerJ       Date:  2018-09-12       Impact factor: 2.984

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.